No Data
No Data
It May Be Possible That Jilin Province Huinan Changlong Bio-pharmacy Company Limited's (HKG:8049) CEO Compensation Could Get Bumped Up
Key Insights Jilin Province Huinan Changlong Bio-pharmacy to hold its Annual General Meeting on 28th of May CEO Hong Zhang's total compensation includes salary of CN¥273.0k The total compensation
A record high! The total number of clinical trials exceeded 4,000 in 2023
According to the report, in 2023, the total number of clinical trials registered on the drug clinical trial registration and information disclosure platform surpassed 4,000 for the first time, reaching 4,300 (in terms of CTR), the highest total number of registrations in history, an increase of 26.1% over the total number of registrations in 2022.
Jilin Changlong Pharmaceutical (08049) will pay a special dividend of 0.0625 yuan per share on July 16
Jilin Changlong Pharmaceutical (08049) announced that the company will pay a special dividend per share on July 16, 2024...
吉林長龍藥業:宣派及派付特別股息及 暫停辦理股份過戶登記手續
吉林長龍藥業:董事會會議通告及建議宣派及派付特別股息
Jilin Changlong Pharmaceutical (08049) announced annual results. Profit attributable to shareholders of 148 million yuan decreased by 23.43% year-on-year
Jilin Changlong Pharmaceutical (08049) announced results for the year ended December 31, 2023, and the group obtained revenue...
No Data